Acute cocaine treatment increases thimet oligopeptidase in the striatum of rat brain  by Dalio, Fernanda M. et al.
Biochemical and Biophysical Research Communications 419 (2012) 724–727Contents lists available at SciVerse ScienceDirect
Biochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate /ybbrcAcute cocaine treatment increases thimet oligopeptidase in the striatum of rat brain
Fernanda M. Dalio a, Bruna Visniauskas b, Eliane S. Bicocchi e, Juliana C. Perry b, Rodrigo Freua a,
Tarsis F. Gesteira c, Helena B. Nader c, Maurício F.M. Machado a, Sergio Tuﬁk b, Emer S. Ferro f,
Monica L. Andersen b, Cláudio A.B. Toledo e, Jair R. Chagas b,d, Vitor Oliveira a,⇑
aDepartamento de Biofísica, Universidade Federal de São Paulo (UNIFESP), SP, Brazil
bDepartamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), SP, Brazil
cDepartamento de Bioquímica, Universidade Federal de São Paulo (UNIFESP), SP, Brazil
dDepartamento de Biociências, Universidade Federal de São Paulo (UNIFESP), Brazil
e Laboratório de Neurociências, Universidade Cidade de São Paulo (UNICID), Brazil
fDepartamento de Biologia Celular e Desenvolvimento, Universidade de São Paulo (USP), SP, Brazila r t i c l e i n f o
Article history:
Received 8 February 2012
Available online 24 February 2012
Keywords:
Cocaine
EC3.4.24.15
Neuropeptidase
Striatum
Thimet oligopeptidase0006-291X/ 2012 Elsevier Inc. Open access under the E
doi:10.1016/j.bbrc.2012.02.088
Abbreviations: EDDnp, N-[2,4-dinitrophenyl]-eth
obenzoyl; Aib, a-aminoisobutyric acid; QFs, quen
(7-methoxycoumarin-4acetyl-Pro-Leu-Gly-Pro-dLys-(
N-[1-(R,S)-carboxy-3-phenylpropyl]Ala-Aib-Tyr-p-am
carboxyl-3-phenylpropyl]Ala-Ala-Tyr-p-aminobenzoa
ﬂuorescence.
⇑ Corresponding author. Address: Departamento
Federal de São Paulo (UNIFESP), Rua Pedro de Toled
032, Brazil.
E-mail address: vitor.oliveira@unifesp.br (V. Oliveia b s t r a c t
Many studies indicate that thimet oligopeptidase (EC3.4.24.15; TOP) can be implicated in the metabolism
of bioactive peptides, including dynorphin 1–8, a-neoendorphin, b-neoendorphin and GnRH. Further-
more, the higher levels of this peptidase are found in neuroendocrine tissue and testis. In the present
study, we have evaluated the effect of acute cocaine administration in male rats on TOP speciﬁc activity
and mRNA levels in prosencephalic brain areas related with the reward circuitry; ventral striatum, hip-
pocampus, and frontal cortex. No signiﬁcant differences on TOP speciﬁc activity were detected in the hip-
pocampus and frontal cortex of cocaine treated animals compared to control vehicle group. However, a
signiﬁcant increase in activity was observed in the ventral striatum of cocaine treated-rats. The increase
occurred in both, TOP speciﬁc activity and TOP relative mRNA amount determined by real time RT-PCR.
As TOP can be implicated in the processing of many neuropeptides, and previous studies have shown that
cocaine also alters the gene expression of proenkephalin and prodynorphin in the striatum, the present
ﬁndings suggest that TOP changes in the brain could play important role in the balance of neuropeptide
level correlated with cocaine effects.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Changes in dopaminergic neurotransmission are implicated in
alterations of the opioid system, including opioid peptides like
dynorphins, enkephalins, endorphins and also in opioid receptors
[1–3].
Reciprocally, the activation of opioid receptors can increase the
levels of extracellular dopamine in the nucleus accumbens [4]. In
particular, the delta-opioid system seems to be strongly related
to the cocaine addiction effects [3–5]. Thimet oligopeptidase (EC
3.4.24.15; TOP) is a proteolytic enzyme, largely distributed in thelsevier OA license. 
ylenediamine; Abz, o-amin-
ched ﬂuorescence substrate
2,4-dinitrophenyl); JA-2,
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de Biofísica, Universidade
o, 669 São Paulo, SP 04039-
ra).central nervous system, able to generate delta-opioid agonists like
Met- and Leu-enkephalin.
TOP was initially detected and puriﬁed from rat brain homoge-
nates [6]. TOP is a zinc-dependent peptidase of the metallopepti-
dase M3 family that contains the HEXXH motif in its primary
sequence [7–9]. A distinguishing feature of this peptidase is that
its catalytic center is located in a deep channel that only provides
access to short peptides making this peptidase an enzyme special-
ized in the metabolism of oligopeptides [9,10]. Studies using
speciﬁc inhibitors have suggested that TOP cleaves bioactive pep-
tides inside and outside the central nervous system [11–13]. In
vitro, TOP hydrolyses many substrates, including bradykinin (BK),
neurotensin (NT), GnRH (gonadotrophin-release hormone), b-neo-
endorphin, a-neoendorphin, dynorphin 1–8 [14] and nociceptin/
orphanin [11]. The participation of this enzyme in the processing
of GnRH (also called luteinizing hormone releasing hormone
LHRH) has been recently reviewed [15]. TOP activity may be con-
trolled by phosphorylation [16,17] and/or by intermolecular disul-
ﬁde bonds leading to inactive oligomers [18,19]. Moreover, an
endogenous inhibitor of TOP has not been described and the half
life of TOP in the cytoplasm is also unknown. Trying to better
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described that TOP is differentially regulated in neuroendocrine
and spermatid cell lineages by a transcription factor binding
to SRY (sex-determining region Y), CAAT box and CREB (cAMP-
response element-binding protein) promoter consensus sequences
[21,22].
The transcription factor CREB has been implicated in the
expression control of many proteins upon acute cocaine adminis-
tration, specially in the ventral striatum region and nucleus accum-
bens [23]. The resultant changes in CREB activity in the striatum
after cocaine administration is a well-documented event [23].
However, the identiﬁcation of the proteins that are consequently
altered by this CREB modulation is currently under investigation,
despite the fact that strong efforts have been carried out in this
way [24].
Therefore, due to the above cited possible involvement of TOP in
the metabolism of neuropeptides related with cocaine effects
(b-neoendorphin, a-neoendorphin, and dynorphin 1–8) and the
described CREB promoter consensus sequence that can control
TOP expression, in the present work, we investigated if TOP could
then be regulated by cocaine administration. For this purpose, we
evaluated the effect of an acute cocaine administration in male rats
on TOP speciﬁc activity and mRNA levels at the prosencephalic
brain areas related with the reward circuitry; ventral striatum,
hippocampus, and frontal cortex.2. Materials and methods
All procedures here were conducted according to an approved
institutional animal experimentation protocol (Committee of Ethi-
cal Research; Approval No. 1001/09), which follows the Guide for
the Care and Use of Laboratory Animals in Research (in accordance
with the National Institutes of Health, USA).
2.1. Animals and drug administration
Male Wistar rats were maintained in a temperature-controlled
room (23 ± 1 C). A group of 8 rats was acutely injected with co-
caine (7 mg/kg; ip) whereas the control group was administrated
with saline solution. After 6 h the brains were collected for the
TOP measurement assays. For the activity measurements, other 2
groups (cocaine and saline) had the brains collected only 1 h after
the drug treatment.
MaleWistar rats (3 months of age)were obtained fromCEDEME–
Universidade Federal de São Paulo (UNIFESP). The animals were
housed in a room maintained at 22 C in 12:12 h light–dark cycle
(lights on at 07:00 am and off at 19:00 h) inside standard polypro-
pylene cages.
Cocaine hydrochloride (Sigma Chemical Co., St. Louis, MO, USA)
was freshly dissolved in saline solution. Intraperitoneal (ip) injec-
tions were given at a constant volume of 1 mL/kg. Naive subjects
were randomly assigned to 2 treatment groups (n = 8 each group),
saline and cocaine administration. A single dose of cocaine 7 mg/kg
or saline was administered intraperitoneally to the rats at 7:30 am
only 1 day at the same time. Six hours after the single dose the
animals were decapitated with minimum discomfort.
2.2. TOP activity measurements
TOP-like activity in tissue extracts samples were quantiﬁed
spectroﬂuorometrically by the hydrolysis of the FRET sub-
strate QFS (7-methoxycoumarin-4acetyl-Pro-Leu-Gly-Pro-dLys-
(2,4-dinitrophenyl). The assays were conducted in the absence
and in the presence of a speciﬁc TOP inhibitor JA-2 (N-[1-(R,S)-car-
boxy-3-phenylpropyl]Ala-Aib-Tyr-p-aminobenzoate) [25], and theactivity attributed to the TOP-like was the activity inhibited by this
speciﬁc inhibitor.2.3. Detection of TOP by quantitative real-time PCR
TOP, b-actin and GAPDH mRNA expression in tissues were
assessed by SYBR Green real-time PCR using 10 ng of total cDNA,
SYBR Green Universal Master Mix (Applied Biosystems), and the
following set of primers independently: TOP (50TGATGTGGAGATG
AGCATGAGGCA-30; 50-GGCTTCAGTGAGTCTTTCGGGAT30, GenBank
Accession No.: NM_172075.2), b-actin (50-AGGCCAACCGTGAAAA
GATG-30 and 50CCAGAGGCATACAGGGACAAC-30, GenBank Acces-
sion No.: NM_031144.2) and GAPDH (50-TGCCCCCATGTTTGT
GATG-30 and 50-CTGACAATCTTGAGGGAGTTGT-30, GenBank Acces-
sion No.: NM_017008). TOP, b-actin and GAPDHmRNA expressions
were obtained from the cycle threshold (Ct) associated with the
exponential growth of the PCR products. Quantitative values for
TOP mRNA expression were obtained by the parameter 2DDCt, in
which DCt represents the subtraction of the b-actin or the GAPDH
Ct values from the TOP Ct values.2.4. Statistical analysis
Values shown are expressed in mean ± standard error of mean
(SEM). Student-t test was used to analyse the data. P < 0.05 were
considered statistically signiﬁcant.3. Results and discussions
Fig. 1 shows the results obtained in the TOP-like activity mea-
surements. A signiﬁcant increase of TOP-like activity (P < 0.05)
was observed in the striatum of the cocaine treated rats (Fig. 1)
in comparison with the saline control group when the animals
were euthanized 6 h after the drug treatment. As stated in the
introductory section TOP activity can be controlled by phosphory-
lation [16] and/or by inactive dimmer formation through intermo-
lecular disulﬁde bonds [18,19]. However, no signiﬁcant changes on
TOP activity were observed in either tissue in additional activity
measurements performed in a group of animals euthanized only
1 h after drug administration (data not shown), what ruled out
the possibility that such fast acting elements were controlling
TOP activity. Furthermore, no endogenous inhibitor of TOP is de-
scribed to date and TOP has no pre- or pro-region which could con-
trol its activity. The direct inhibition or activation of TOP hydrolytic
activity by cocaine was also tested but, no effect in the TOP activity
was observed with cocaine concentrations up to 1 mM (data not
shown). Therefore, the results suggest that the increased TOP activ-
ity observed in the striatum after cocaine administration was the
result of newly synthesized protein, controlled at the transcrip-
tional level. Actually, it was supported by the following quantita-
tive real-time PCR assays (Fig. 2). As observed in the speciﬁc
activity assays, only in the striatum of cocaine treated rats signiﬁ-
cant increases of TOP mRNA levels were detected by the quantita-
tive real time PCR (P = 0.001 with b-actin as control and P = 0.03
with GAPDH as control). No signiﬁcant changes in the mRNA TOP
levels were found in hippocampus and frontal cortex of cocaine
treated rats (Fig. 2).
The increase of cAMP-response-element-binding protein (CREB)
activity in the striatum of rat brains, following cocaine administra-
tion, is a well documented event [23]. It has also been described
that TOP expression is differentially regulated in neuroendrocrine
sites by the transcription factor binding CREB promoter consensus
sequences [22,26]. Taken together these observations provide a
reasonable explanation for the increased TOP mRNA transcription
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Fig. 1. Speciﬁc activity (AUF/min/lg of total protein) measured by the inhibition of the FRET substrate hydrolysis by the speciﬁc TOP inhibitor (JA-2). Values are expressed as
the mean ± standard error of mean (SEM). ⁄P < 0.05. Open bars – saline, black bars – cocaine.
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Fig. 2. TOP mRNA measured using reverse transcription and quantitative real-time polymerase chain reaction (qPCR). The plots show the ratio of the estimated TOP mRNA
level detected in the cocaine treated animals (open bars) and the control level in the saline solution treated rats (black bars), all normalized by the b-actin mRNA levels or
GAPDH mRNA levels. Values are expressed as the mean ± standard error of mean (SEM).⁄P < 0.05.
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the cocaine treated rats (Fig. 1).
Opioid peptides are involved in the mechanisms of addiction
adding on the reward circuits and reinforcement [3,5]. Previous
studies showed that CREB can also control the gene expression of
proenkephalin and prodynorphin in the nucleus accumbens [23].
Recent evidences strongly suggest that a delta-opioid speciﬁc
antagonist, but neither mu- or gamma-opioid, was able to reverse
the conditioned place preference induced by cocaine, while potent
delta-opioid agonists were able to reinstall the rewarding cocaine
effects [27]. As recently reviewed, pharmacological and genetic re-
search lines point out delta opioid receptor activity to be involved
on addictive behaviors of a number of drugs of abuse [28].
As TOP can be implicated in the processing of opioid peptides,
including, b-neoendorphin, a-neoendorphin, dynorphin 1–8 and
nociceptin/orphanin, modiﬁcations on TOP activity can potentially
result in alterations in the metabolism of these neuropeptides and
in vivo could be related to cocaine addiction. It is also tempting to
speculate that, at least partially, delta-opioid receptor desensitiza-
tion observed at chronic cocaine administration, could be
attributed to the increase of delta-opioid peptides, like Met- or
Leu-enkephalin, generated by the increases TOP activity upon the
effect of cocaine. Further studies will allow us to specify the areas
of tissues where the presented changes in TOP take place and
evaluate the effect of these changes on the levels and activity of
involved neuropeptides and receptors in vivo.
Our results suggest the involvement of brain TOP in the neuro-
peptides related effects of cocaine administration.
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